Yi Lin

机构：Sun Yat-sen University, Peking University, Sichuan University, West China Hospital of Sichuan University, The Future University, Beijing Advanced Sciences and Innovation Center, Eighth Affiliated Hospital of Sun Yat-sen University, Faculdade do Futuro · ORCID：0000-0002-8916-7901

发表论文 47 篇 · 总被引 2133 次 · h-index 22

代表论文

• Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy (2023 · Advanced Materials · 被引 468)
• Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP (2022 · Biomaterials Science · 被引 127)
• Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo (2024 · ACS Nano · 被引 79)
• Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond (2023 · Biophysics Reports · 被引 64)
• Folate Receptor‐Mediated Delivery of Cas9 RNP for Enhanced Immune Checkpoint Disruption in Cancer Cells (2022 · Small · 被引 57)
• Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy (2022 · Frontiers in Immunology · 被引 46)